For the Quarter Ending March 2026
Monosulfiram Prices in North America
- In North America, the Monosulfiram Price Index showed a moderate upward trend during Q1 2026, supported by steady pharmaceutical demand and controlled import availability.
- The average Monosulfiram Price Index remained firm, reflecting balanced inventories and stable distribution across healthcare supply chains.
- Monosulfiram Spot Price increased during the quarter as suppliers faced limited import inflows and extended lead times.
- The Monosulfiram Production Cost Trend moved higher due to rising costs of key intermediates such as carbon disulfide and dimethylamine, along with elevated energy expenses.
- Monosulfiram Demand Outlook remained stable, driven by its downstream uses in pharmaceutical formulations (particularly topical treatments), veterinary applications, and specialty chemical segments.
- Demand from healthcare procurement channels and pharmaceutical distributors supported consistent consumption levels.
- The Monosulfiram Price Index was supported by moderate inventory tightening and cautious restocking activity.
- Monosulfiram Price Forecast indicates a stable-to-firm outlook, influenced by feedstock cost trends and steady pharmaceutical demand.
Why did the price of Monosulfiram change in March 2026 in North America?
- Prices increased in March 2026 due to higher feedstock costs, which raised the Monosulfiram Production Cost Trend.
- Limited import availability and longer lead times supported the Monosulfiram Price Index.
- Stable demand from pharmaceutical and veterinary sectors reinforced the upward pricing trend.
Monosulfiram Prices in APAC
- In India, the Monosulfiram Price Index rose by 3.806% quarter-over-quarter, driven by tighter imports and higher conversion costs.
- The average Monosulfiram price for the quarter was approximately USD 16456.53/MT, reflecting strengthened Ex-Mumbai offers.
- Monosulfiram Spot Price tightened in coastal warehouses as Nhava Sheva congestion delayed inbound volumes, supporting prompt market offers.
- Monosulfiram Price Forecast shows modest near-term increases as buyers front-load purchases ahead of public health procurement cycles.
- Monosulfiram Production Cost Trend rose as carbon disulphide and dimethylamine costs climbed with crude-driven energy inflation.
- Monosulfiram Demand Outlook remains firm with pharmaceutical and veterinary formulators replenishing inventories ahead of seasonal treatment campaigns.
- Monosulfiram Price Index volatility increased in March due to combined supply constraints and accelerated institutional procurement.
- Export delays and limited ISO tank availability constrained flows, reducing spot offerings and supporting sustained domestic price firmness.
Why did the price of Monosulfiram change in March 2026 in APAC?
- Extended Nhava Sheva port congestion delayed intermediates, tightening supply and lengthening lead times for formulators.
- Rising carbon disulphide and dimethylamine costs elevated production expenses, pushing domestic conversion costs marginally higher.
- Accelerated public health tendering increased prompt demand, draining spot inventories and reinforcing upward price momentum.
Monosulfiram Prices in Europe
- In Europe, the Monosulfiram Price Index showed a moderate upward trend during Q1 2026, supported by steady pharmaceutical demand and constrained supply conditions.
- The average Monosulfiram Price Index remained firm throughout the quarter, reflecting balanced imports and controlled domestic production.
- Monosulfiram Spot Price increased during the quarter as limited availability and longer lead times tightened prompt supply across key distribution hubs.
- The Monosulfiram Production Cost Trend moved upward due to higher costs of key intermediates such as carbon disulfide and dimethylamine, along with rising energy prices.
- Monosulfiram Demand Outlook remained stable-to-firm, driven by its key downstream uses in pharmaceuticals (as a topical scabicide), veterinary formulations, and specialty chemical applications.
- Demand from healthcare procurement programs and pharmaceutical distributors supported consistent consumption.
- The Monosulfiram Price Index was further supported by moderate inventory drawdowns and cautious restocking behavior by buyers.
- Monosulfiram Price Forecast indicates a stable-to-firm outlook, influenced by feedstock cost volatility and ongoing healthcare sector demand.
Why did the price of Monosulfiram change in March 2026 in Europe?
- Prices increased in March 2026 due to rising feedstock and energy costs, which elevated the Monosulfiram Production Cost Trend.
- Limited supply availability and import delays supported the Monosulfiram Price Index.
- Steady demand from pharmaceutical and veterinary sectors reinforced upward pricing momentum.
For the Quarter Ending December 2025
North America
- In North America, the Monosulfiram Price Index eased modestly quarter-over-quarter, reflecting stable domestic availability and steady import inflows.
- The average Monosulfiram price for the quarter was approximately USD 16,200.00/MT, based on CFR U.S. Gulf and East Coast ports.
- Monosulfiram Spot Prices softened as suppliers maintained disciplined offers amid adequate warehouse inventories.
- Monosulfiram Production Cost Trend showed moderate pressure from feedstock and regulatory compliance, but overall costs remained stable.
- Monosulfiram Demand Outlook remained cautious, with pharmaceutical buyers adhering to routine procurement schedules and limiting spot buying.
- Monosulfiram Price Forecast suggested mild downward bias unless feedstock inflation or unexpected tendering increases demand.
- Price Index movements were balanced by steady domestic plant output and normalized imports.
- Distributors prioritized inventory drawdowns over aggressive restocking, moderating market volatility.
Why did the price of Monosulfiram change in December 2025 in North America?
- Improved domestic plant availability and normalized import flows increased supply coverage, easing spot premiums.
- Stable carbon disulphide and compliance costs prevented upward pressure on offers.
- Routine pharmaceutical procurement and predictable tender volumes limited near-term price recovery.
APAC
- In India, the Monosulfiram Price Index fell by 1.12% quarter-over-quarter, reflecting smoother domestic availability improvements.
- The average Monosulfiram price for the quarter was approximately USD 15853.15/MT, per recent trade surveys.
- Monosulfiram Spot Price softened as increased plant output reduced short-term premiums, easing procurement pressures across buyers.
- Monosulfiram Production Cost Trend saw gains from carbon disulphide costs, compliance retrofits impacting conversion expenses.
- Monosulfiram Demand Outlook remained muted with routine pharma purchasing and public tenders restraining buying activity.
- Monosulfiram Price Forecast indicates gentle downward bias near-term unless feedstock inflation or renewed tendering tightens supply.
- Monosulfiram Price Index dynamics reflected inventory rebuilds following scrubber retrofits, which restored availability and trimmed spot volatility.
- Export volumes to Bangladesh and Nepal stayed steady, offering minor support while domestic stock adjustments determined prices.
Why did the price of Monosulfiram change in December 2025 in APAC?
- Restored domestic plant operations increased availability, rebuilding inventories and reducing spot premiums across regional supply chains.
- Seasonal lull and muted public tenders lowered bulk procurement, removing upwards pressure from domestic demand in December.
- Stable carbon disulphide costs and improved port fluidity constrained conversion and logistics cost pass-through during December.
Europe
- In Europe, the Monosulfiram Price Index declined slightly quarter-over-quarter, reflecting steady domestic availability and moderated import flows.
- The average Monosulfiram price for the quarter was approximately USD 16,000.00/MT, based on CFR assessments across key European ports.
- Monosulfiram Spot Prices softened as distributors replenished inventories while import arrivals normalized, easing premium pressures.
- Monosulfiram Production Cost Trend saw moderate pressure from carbon disulphide feedstock and compliance-related expenses, but overall conversion costs remained controlled.
- Monosulfiram Demand Outlook remained muted, with pharmaceutical formulators limiting spot purchases and public tenders maintaining predictable volumes.
- Monosulfiram Price Forecast indicated gentle downward bias unless feedstock prices or tender volumes change sharply.
- Price Index movements were tempered by balanced warehouse inventories and controlled replenishment schedules.
- European distributors relied on existing coverage, with steady imports offering marginal support to pricing.
Why did the price of Monosulfiram change in December 2025 in Europe?
- Stabilized import flows and replenished distributor inventories reduced urgency-driven buying, softening the Price Index.
- Controlled feedstock and compliance costs limited upstream pressure for price increases.
- Muted tender activity and cautious spot purchasing by formulators constrained short-term upside.
For the Quarter Ending September 2025
North America
- In North America, the Monosulfiram Price Index rose by ~0.7% quarter-over-quarter, supported by drawn-down distributor inventories and steady end-use demand.
- The average Monosulfiram price for the quarter was approximately USD 16,100.00/MT (conservative estimate using regional quotes and import parity).
- Monosulfiram Spot Price remained firm as buyers replenished low stocks after seasonal consumption and select plant maintenance tightened prompt availability briefly.
- Monosulfiram Demand Outlook is constructive from veterinary, personal care and topical pharma sectors, underpinning steady procurement into Q4.
- Monosulfiram Production Cost Trend was stable with adequate feedstock supplies and normalised manufacturing runs following turnarounds.
- Monosulfiram Price Forecast suggests modest upward bias into Q4 as restocking and ongoing export obligations support near-term demand.
- Low downstream inventories in several distribution hubs tightened immediate availability, while regular shipments from producers maintained overall cadence.
- Reliable port throughput and inland trucking contained logistical risk, so price resilience primarily reflected inventory and demand balances.
Why did the price of Monosulfiram change in September 2025 in North America?
- Drawn-down inventories and seasonal monsoon-equivalent demand in end-use sectors prompted restocking, tightening prompt availability and supporting prices.
- Stable feedstock and manufacturing runs kept production-cost pressure limited, so price moves were driven by inventory/demand dynamics rather than input-cost spikes.
- Smooth logistics and steady freight conditions prevented landed-cost volatility, allowing regional supply-demand balances to set transactional pricing.
APAC
- In India, the Monosulfiram Price Index fell by 0.33% quarter-over-quarter, reflecting subdued downstream demand and procurement.
- The average Monosulfiram price for the quarter was approximately USD 16032.41/MT, reflecting Mumbai trading and production.
- Monosulfiram Spot Price remained firm in August due to restocking, limited inventories and steady demand.
- Monosulfiram Demand Outlook indicates sustained monsoon-driven requirements from veterinary, personal care and topical pharmaceutical applications.
- Monosulfiram Production Cost Trend remained stable as feedstock availability and manufacturing runs showed no disruptions.
- Monosulfiram Price Forecast reflects modest upward pressure into Q4 as downstream buyers replenish depleted inventories.
- Monosulfiram Price Index movements were primarily demand-led, with distributors reducing purchases and prioritizing consumption-driven procurement.
- Low downstream inventories and export obligations tightened near-term availability, supporting price resilience amid monsoon purchasing.
Why did the price of Monosulfiram change in September 2025 in APAC?
- Seasonal monsoon-driven demand in veterinary and personal care sectors increased final-quarter consumption, tightening immediate market availability.
- Downstream inventories were drawn down earlier, prompting restocking and contributing to upward price pressure in September.
- Production remained stable with no feedstock constraints, while handling charges and export obligations added cost support.
Europe
- In Europe, the Monosulfiram Price Index fell by ~0.5% quarter-over-quarter, reflecting generally subdued procurement but pockets of restocking.
- The average Monosulfiram price for the quarter was approximately USD 16,500.00/MT (conservative estimate based on limited regional transaction data and import parity).
- Monosulfiram Spot Price showed firmness in select markets where distributors replenished low stocks, while overall spot liquidity remained muted.
- Monosulfiram Demand Outlook indicates steady requirements from veterinary and topical formulations, with seasonal buying supporting measured purchases.
- Monosulfiram Production Cost Trend stayed stable, with feedstock availability adequate and energy costs only modestly variable.
- Monosulfiram Price Forecast points to modest firming into Q4 as replenishment by distributors and seasonal demand lift near-term enquiry.
- Low-to-moderate distributor inventories in some markets tightened prompt availability, while other markets bore carryover stocks—producing mixed regional Price Index signals.
- Efficient port handling and inland logistics preserved supply continuity, limiting abrupt price moves despite localized tightness.
Why did the price of Monosulfiram change in September 2025 in Europe?
- Seasonal and consumption-driven restocking in veterinary and personal care segments supported localized price firmness, while other markets with higher inventories kept broader pressure modest.
- Stable feedstock supply and steady production costs removed major upward cost drivers, so price moves were largely demand/inventory-led.
- Smooth logistics and predictable freight dynamics allowed procurement timing to determine transactional pricing rather than freight or disruption-related premiums.
For the Quarter Ending June 2025
Asia Pacific (APAC)
Why did the price change in July 2025?
- The Price Index for Monosulfiram in Asia dipped further in early July 2025 as distributors remained cautious due to existing inventory surpluses.
- In India June’s Monosulfiram Spot Price stood at USD 15,989.51 per metric ton and reflected a 0.72% decline.
- The Monosulfiram Spot Price in Asia had earlier increased in April and May 2025 that was driven by seasonal demand from pharmaceuticals and personal care segments. The prices began to decline in June due to demand fatigue and surplus stock conditions.
- The Monosulfiram Price Forecast turned bearish in June as buyers abstained from fresh procurement amidst tepid downstream off-take, compounded by monsoon-related lifestyle shifts that curtailed product usage.
- Throughout Q2, the Monosulfiram Production Cost Trend remained largely stable, as feedstock availability and operating rates at Indian manufacturing units continued uninterrupted.
- Despite initial bullish procurement behaviour in April, June saw visible demand weakening from key sectors like derma, personal hygiene, and animal care, softening the Monosulfiram Demand Outlook.
- Strategic stockpiling in April and May led to bloated inventories by June, which discouraged replenishment and pressured market sentiment downward.
- Efficient inland distribution persisted across India, even during monsoon progression, preventing any supply-side disruption or logistics-induced price volatility.
- Domestic manufacturers maintained regular production schedules, with supply discipline observed in May contributing to temporary price firmness.
- With Q2 ending on a subdued note, July opened with restrained spot purchases, as importers and end-users monitored inventory drawdowns and market corrections.
North America
- Why did the price change in July 2025?
- The Monosulfiram Price Index in North America showed signs of softening in early July 2025 as consumer healthcare and veterinary distributors scaled back fresh procurement amid adequate inventories and moderate summer demand.
- The Monosulfiram Spot Price in April and May saw gradual firming as procurement accelerated for summer healthcare formulations, particularly for veterinary skin care and antifungal topical products.
- By June, downstream demand signals began to decelerate slightly, triggering conservative inventory planning, which reflected in a flat-to-weak Monosulfiram Price Forecast.
- Stable production and secure feedstock access kept the Monosulfiram Production Cost Trend neutral throughout the quarter in North America.
- Demand from dermatology and hygiene segments remained moderate, influenced by a less severe fungal outbreak season and greater consumer inventory optimization.
- No major import reliance or supply delays were reported; domestic formulators maintained scheduled procurement tied to monthly usage rates.
- Distributors reported higher-than-average stock availability in June, having procured aggressively during the early Q2 price incline phase.
- North American formulators strategically spaced out their purchase cycles post-May, leading to subdued market movement in June.
- The Q2 cycle concluded with a relatively balanced market, with early-quarter strength offset by end-quarter caution, ahead of a modest July slowdown in Monosulfiram Demand Outlook.
Europe
- Why did the price change in July 2025?
- In Europe, the Price Index for Monosulfiram declined marginally in July 2025 due to sluggish consumption recovery and cautious stockholding following weak Q2 off-take in dermatological and veterinary product lines.
- The Monosulfiram Spot Price in Europe showed modest strength in April amid early seasonal demand, particularly from personal care manufacturers anticipating summer skincare product launches.
- May registered stable procurement from pharmaceutical manufacturers, but lacked significant momentum, with Monosulfiram Price Forecast signals remaining neutral.
- By June, demand contraction set in as downstream buyers, facing unexciting consumer movement, deferred procurement — a trend echoed in the broader Monosulfiram Demand Outlook.
- European buyers prioritized lean inventory models, especially in Western Europe, to avoid surplus accumulation observed during Q1 and early Q2.
- The Monosulfiram Production Cost Trend remained stable in Europe, with no supply-side inflation reported. Local manufacturing operated on demand-based planning.
- Regional distribution logistics functioned efficiently throughout Q2, with no external disruptions affecting availability or delivery cycles.
- Export-reliant buyers in Eastern Europe showed weaker activity in May and June due to soft purchasing cues from Middle East and African clients.
- Q2 closed with European Monosulfiram markets entering July cautiously, maintaining only operational inventories and trimming future spot purchases.
